Cancer’s strongest gene switches push DNA into damaging overdrive, creating repeated breaks and repairs that may fuel tumor ...
A discovery from Mayo Clinic researchers in Rochester shows a certain lung cancer treatment can also be used to treat aggressive cases of ovarian cancer. The study published by clinic researchers in ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Dr Liu is a ...
Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...
While the genes involved can differ, this example illustrates how most cancers arise. Accumulated DNA mutations, acquired either over time (ageing naturally leads to some DNA mistakes) or from ...
BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.
Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results